# A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years

> **NCT01629407** · — · COMPLETED · sponsor: **Allergan** · enrollment: 315 (actual)

## Conditions studied

- Glaucoma, Open-Angle

## Interventions

- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT01629407
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 315 (ACTUAL)
- **Last updated:** 2013-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01629407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01629407, "A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01629407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*